155 related articles for article (PubMed ID: 25432885)
1. Integrating health-related quality of life findings from randomized clinical trials into practice: an international study of oncologists' perspectives.
Rouette J; Blazeby J; King M; Calvert M; Peng Y; Meyer RM; Ringash J; Walker M; Brundage MD
Qual Life Res; 2015 Jun; 24(6):1317-25. PubMed ID: 25432885
[TBL] [Abstract][Full Text] [Related]
2. Patterns of reporting health-related quality of life outcomes in randomized clinical trials: implications for clinicians and quality of life researchers.
Brundage M; Bass B; Davidson J; Queenan J; Bezjak A; Ringash J; Wilkinson A; Feldman-Stewart D
Qual Life Res; 2011 Jun; 20(5):653-64. PubMed ID: 21110123
[TBL] [Abstract][Full Text] [Related]
3. A knowledge translation challenge: clinical use of quality of life data from cancer clinical trials.
Brundage M; Bass B; Jolie R; Foley K
Qual Life Res; 2011 Sep; 20(7):979-85. PubMed ID: 21279446
[TBL] [Abstract][Full Text] [Related]
4. The future of Cochrane Neonatal.
Soll RF; Ovelman C; McGuire W
Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
[TBL] [Abstract][Full Text] [Related]
5. Health-related quality of life in early breast cancer.
Groenvold M
Dan Med Bull; 2010 Sep; 57(9):B4184. PubMed ID: 20816024
[TBL] [Abstract][Full Text] [Related]
6. Radiation oncologists' scope of practice and role in cancer management in Australia, New Zealand, and Singapore: Are we clinicians or technicians?
Leung J; James M; Adams G; Gupta N
J Med Imaging Radiat Oncol; 2023 Oct; 67(7):769-776. PubMed ID: 37469112
[TBL] [Abstract][Full Text] [Related]
7. Health-related quality of life measurement in randomized clinical trials in surgical oncology.
Blazeby JM; Avery K; Sprangers M; Pikhart H; Fayers P; Donovan J
J Clin Oncol; 2006 Jul; 24(19):3178-86. PubMed ID: 16809741
[TBL] [Abstract][Full Text] [Related]
8. The role of health-related quality of life outcomes in clinical decision making in surgery for esophageal cancer: a systematic review.
Parameswaran R; McNair A; Avery KN; Berrisford RG; Wajed SA; Sprangers MA; Blazeby JM
Ann Surg Oncol; 2008 Sep; 15(9):2372-9. PubMed ID: 18626719
[TBL] [Abstract][Full Text] [Related]
9. Patient-reported outcomes in randomized clinical trials: development of ISOQOL reporting standards.
Brundage M; Blazeby J; Revicki D; Bass B; de Vet H; Duffy H; Efficace F; King M; Lam CL; Moher D; Scott J; Sloan J; Snyder C; Yount S; Calvert M
Qual Life Res; 2013 Aug; 22(6):1161-75. PubMed ID: 22987144
[TBL] [Abstract][Full Text] [Related]
10. Barriers in conducting clinical trials in oncology in the developing world: A cross-sectional survey of oncologists.
Dandekar M; Trivedi R; Irawati N; Prabhash K; Gupta S; Agarwal JP; D'Cruz AK
Indian J Cancer; 2016; 53(1):174-7. PubMed ID: 27146772
[TBL] [Abstract][Full Text] [Related]
11. The standard of reporting of health-related quality of life in clinical cancer trials.
Lee CW; Chi KN
J Clin Epidemiol; 2000 May; 53(5):451-8. PubMed ID: 10812316
[TBL] [Abstract][Full Text] [Related]
12. Perceptions of barriers and facilitators to early integration of pediatric palliative care: A national survey of pediatric oncology providers.
Dalberg T; McNinch NL; Friebert S
Pediatr Blood Cancer; 2018 Jun; 65(6):e26996. PubMed ID: 29418063
[TBL] [Abstract][Full Text] [Related]
13. A preliminary survey of oncologists' perceptions of quality of life information.
Bezjak A; Ng P; Taylor K; MacDonald K; Depetrillo AD
Psychooncology; 1997 Jun; 6(2):107-13. PubMed ID: 9205968
[TBL] [Abstract][Full Text] [Related]
14. ONCOLOGISTS' BARRIERS AND FACILITATORS FOR ONCOTYPE DX USE: QUALITATIVE STUDY.
Roberts MC; Bryson A; Weinberger M; Dusetzina SB; Dinan MA; Reeder-Hayes K; Wheeler SB
Int J Technol Assess Health Care; 2016 Jan; 32(5):355-361. PubMed ID: 27958190
[TBL] [Abstract][Full Text] [Related]
15. Health-related quality-of-life assessments and patient-physician communication: a randomized controlled trial.
Detmar SB; Muller MJ; Schornagel JH; Wever LD; Aaronson NK
JAMA; 2002 Dec; 288(23):3027-34. PubMed ID: 12479768
[TBL] [Abstract][Full Text] [Related]
16. Quality of life assessment in surgical oncology trials.
Avery K; Blazeby JM
World J Surg; 2006 Jul; 30(7):1163-72. PubMed ID: 16794901
[TBL] [Abstract][Full Text] [Related]
17. A survey of Australian and New Zealand clinical practice with neoadjuvant systemic therapy for breast cancer.
Zdenkowski N; Butow P; Mann GB; Fewster S; Beckmore C; Isaacs R; Douglas C; Boyle FM
Intern Med J; 2016 Jun; 46(6):677-83. PubMed ID: 26929045
[TBL] [Abstract][Full Text] [Related]
18. Difficult clinical decisions in gynecological oncology: identifying priorities for future clinical research.
Harrison JD; Carter J; Young JM; Solomon MJ
Int J Gynecol Cancer; 2006; 16(1):1-7. PubMed ID: 16445602
[TBL] [Abstract][Full Text] [Related]
19. Exploration of oncologists' attitudes toward and perceived value of patient-reported outcomes.
Meldahl ML; Acaster S; Hayes RP
Qual Life Res; 2013 May; 22(4):725-31. PubMed ID: 22684493
[TBL] [Abstract][Full Text] [Related]
20. Oncologists' Views on Using Value to Guide Cancer Treatment Decisions.
Gidwani-Marszowski R; Nevedal AL; Blayney DW; Patel M; Kelly PA; Timko C; Ramchandran K; Murrell SS; Asch SM
Value Health; 2018 Aug; 21(8):931-937. PubMed ID: 30098670
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
